You are here

Article Text

Article menu
Download PDFPDF
Editorial
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance

https://doi.org/10.1136/heartjnl-2012-302101

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests GL has served as a consultant for Bayer, Astellas, Merck, AstraZeneca, Sanofi, BMS/Pfizer, Daiichi-Sankyo, Biotronik, Portola and Boehringer Ingelheim and has been on the speakers bureau for Bayer, BMS/Pfizer, Boehringer Ingelheim, and Sanofi Aventis. YA: none declared.

    • Provenance and peer review Commissioned; internally peer reviewed.